← Back
Data updated: Mar 10, 2026
SCIECURE PHARMA INC
NeurologyGastroenterology
SCIECURE PHARMA INC is a generic drug manufacturer focused on Neurology, Gastroenterology.
2017
Since
3
Drugs
-
Trials
29
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
BUDESONIDE 2026-01-26
Labeling
CARBAMAZEPINE 2026-01-05
Labeling
PAROXETINE HYDROCHLORIDE 2025-09-24
BUDESONIDE 2025-09-16
Labeling
CARBAMAZEPINE 2025-08-15
Labeling
CARBAMAZEPINE 2025-07-25
CARBAMAZEPINE 2025-07-01
Labeling
CARBAMAZEPINE 2025-06-23
Labeling
CARBAMAZEPINE 2025-04-16
PAROXETINE HYDROCHLORIDE 2025-03-13
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 86%
1 drugs
Gastroenterology 14%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (1)
Company Info
- First Approval
- 2017-09-28
- Latest
- 2023-03-02
- Applications
- 3